UPDATE | June 23, 2025

Advancing biologics development with next-generation cell line development

  • MAIL

Advancing biologics development with next-generation cell line development image


As biologics grow more complex, cell line development (CLD) must advance with them. This whitepaper explores how Samsung Biologics’ next-generation CLD platforms—S-CHOice® and S-AfuCHO™—are designed to deliver speed, consistency, and enhanced control over product quality. 


Learn how innovations like transposase-mediated integration and high-throughput lectin assays are helping streamline early development and support clinical success. 

Advancing biologics development with next-generation cell line development image


As biologics grow more complex, cell line development (CLD) must advance with them. This whitepaper explores how Samsung Biologics’ next-generation CLD platforms—S-CHOice® and S-AfuCHO™—are designed to deliver speed, consistency, and enhanced control over product quality. 


Learn how innovations like transposase-mediated integration and high-throughput lectin assays are helping streamline early development and support clinical success. 

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required